Masahiko MoriyamaPresident & Representative Director This is Moriyama from T&D Holdings. Thank you very much for taking the time out of your busy schedules...
This article was written by Follow Vasily Zyryanov is an individual investor and writer.He uses various techniques to find both relatively underpriced equities with...
Realty Income (NYSE:O) is among the bluest of the blue-chip REITs and offers investors an attractive current dividend yield and over quarter century dividend...
Overview Automation, Robotics and Artificial Intelligence are keywords, concepts and megatrends that stoke greed and fear in many an investor heart. However, why are...
Protagonist Therapeutics, Inc. (NASDAQ:PTGX) is developing JNJ-2113 (PN-235), an oral IL-23 drug targeting psoriasis, however partner Johnson & Johnson (JNJ) says that until the...
The Biden administration has so far approved over $22 billion in student loan forgiveness for borrowers who were harmed by school misconduct. And the...